EBI EXPONENTIAL BIOTHERAPIES - Trademark Details
Status: 686 - Published For Opposition
Serial Number
87765139
Word Mark
EBI EXPONENTIAL BIOTHERAPIES
Status
686 - Published For Opposition
Status Date
2022-01-11
Filing Date
2018-01-22
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260103, 260521, 261709, 261901 - Incomplete circles (more than semi-circles). Triangles that are completely or partially shaded. Curved line(s), band(s) or bar(s). Spheres.
Published for Opposition Date
2022-01-11
Attorney Name
Law Office Assigned Location Code
N70
Employee Name
INGRAM, KYLE G
Statements
Indication of Colors claimed
The red and gray are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"BIOTHERAPIES"
Description of Mark
The mark consists of a broken circle comprised of a curved red band and a curved gray band. A red triangle appears in the middle of the left band and protrudes into the circle. Within the left side of the circle are two gray polygons of triangular shape with curved corners and lines. To the right of this circular design are the letters "EBI" appearing in a large gray font with the wording "EXPONENTIAL BIOTHERAPIES" appearing in a smaller gray font below.
Goods and Services
medicines, namely, medicines for alleviating or treating vasculogenic disease, medicines for alleviating or treating hemodynamic instabilities, medicines for alleviating or treating diabetes, medicines for alleviating or treating of immune system related diseases and disorders; pharmaceutical drugs, namely, pharmaceutical preparations for alleviating or treating vasculogenic disease, pharmaceutical preparations alleviating or treating hemodynamic instabilities, pharmaceutical preparations for alleviating or treating diabetes, pharmaceutical preparations for alleviating or treating of immune system related diseases and disorders; biopharmaceutical drugs, namely, biopharmaceutical preparations for alleviating or treating vasculogenic disease, biopharmaceutical preparations for alleviating or treating hemodynamic instabilities, biopharmaceutical preparations for alleviating or treating diabetes, biopharmaceutical preparations for alleviating or treating of immune system related diseases and disorders; biopharmaceuticals, namely, biopharmaceuticals for alleviating or treating vasculogenic disease, biopharmaceuticals alleviating or treating hemodynamic instabilities, biopharmaceuticals for alleviating or treating diabetes, biopharmaceuticals for alleviating or treating of immune system related diseases and disorders; synthetic peptides for biopharmaceutical purposes and for pharmaceutical purposes, namely, synthetic peptides for alleviating or treating vasculogenic disease, synthetic peptides for alleviating or treating hemodynamic instabilities, synthetic peptides for alleviating or treating diabetes, synthetic peptides for alleviating or treating of immune system related diseases and disorders; synthetic peptidemimetics for biopharmaceutical purposes and for pharmaceutical purposes, namely, sytnthetic peptidomimetics for alleviating or treating vasculogenic disease, synthetic peptidomimetics for alleviating or treating hemodynamic instabilities, synthetic peptidomimetics for alleviating or treating diabetes, synthetic peptidomimetics for alleviating or treating of immune system related diseases and disorders
Goods and Services
Medical apparatus and instruments; syringes; devices for injecting medicines, pharmaceutical drugs, biopharmaceutical drugs, pharmaceuticals and biopharmaceuticals
Goods and Services
custom manufacture of medicines, pharmaceutical drugs, biopharmaceutical drugs, pharmaceuticals and biopharmaceuticals; treatment of biopharmaceutical and pharmaceutical materials being medicines, biopharmaceutical and pharmaceutical compounds, synthetic peptides and synthetic peptidomimetics; processing of medicines, biopharmaceutical and pharmaceutical compounds, synthetic peptides and synthetic peptidomimetics for others; custom manufacture of medical devices for others
Goods and Services
biopharmaceutical and pharmaceutical research; conducting clinical trials for others in the fields of medicines, synthetic peptides and synthetic peptidomimetics as they relate to use as an ingredient in medicines, biopharmaceuticals, pharmaceuticals, pharmaceutical drugs and biopharmaceutical drugs; scientific research of medicines, synthetic peptides and synthetic peptidomimetics as they relate to use as an ingredient in medicines, biopharmaceuticals and pharmaceuticals, pharmaceutical drugs and biopharmaceutical drugs; development, testing, and inspection of medicines, synthetic peptides and synthetic peptidomimetics as they relate to use as an ingredient in medicines, pharmaceutical drugs, biopharmaceutical drugs, pharmaceuticals and biopharmaceuticals; laboratory services relating to medicines, synthetic peptides, synthetic peptidomimetics, pharmaceutical drugs, biopharmaceutical drugs, pharmaceuticals and biopharmaceuticals, namely, research in the fields of medicines, synthetic peptides, synthetic peptidomimetics, biopharmaceuticals, pharmaceuticals, pharmaceutical drugs and biopharmaceutical drugs; laboratory analysis in the fields of medicines, synthetic peptides, synthetic peptidomimetics, biopharmaceuticals, pharmaceuticals, pharmaceutical drugs and biopharmaceutical drugs; medical research in the fields of medicines, synthetic peptides, synthetic peptidomimetics, biopharmaceuticals, pharmaceuticals, pharmaceutical drugs and biopharmaceutical drugs; scientific research for medical purposes in the fields of medicines, synthetic peptides, synthetic peptidomimetics, biopharmaceuticals, pharmaceuticals, pharmaceutical drugs and biopharmaceutical drugs
Goods and Services
Medical services; consultancy and information services relating to medicines, pharmaceutical drugs, biopharmaceutical drugs, pharmaceuticals and biopharmaceuticals; medical testing; medical and health care services; medical consultancy services; medical, medicinal, biopharmaceutical and pharmaceutical consultancy; medical counselling; medical analyses services
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-02-02
Primary Code
005
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2018-02-02
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-02-02
Primary Code
042
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
HOPE V. SHOVEIN
Address
Please log in with your Justia account to see this address.
Foreign Application Information
| Filing Date | Application Number | Country | Foreign Priority Claim In |
| 2017-12-19 | 017617721 | EU | True |
| True | |||
| True |
Trademark Events
| Event Date | Event Description |
| 2018-01-25 | NEW APPLICATION ENTERED IN TRAM |
| 2018-01-30 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| 2018-02-02 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2018-02-03 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2018-02-07 | ASSIGNED TO LIE |
| 2018-02-08 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| 2018-05-02 | ASSIGNED TO EXAMINER |
| 2018-05-09 | NON-FINAL ACTION WRITTEN |
| 2018-05-09 | NON-FINAL ACTION E-MAILED |
| 2018-05-09 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2018-11-09 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2018-11-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2018-11-10 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2018-11-20 | SUSPENSION LETTER WRITTEN |
| 2018-11-20 | LETTER OF SUSPENSION E-MAILED |
| 2018-11-20 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 2019-06-11 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| 2019-06-15 | SUSPENSION INQUIRY WRITTEN |
| 2019-06-15 | INQUIRY TO SUSPENSION E-MAILED |
| 2019-06-15 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| 2019-12-16 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| 2019-12-19 | ASSIGNED TO LIE |
| 2019-12-26 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2019-12-26 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-01-09 | SUSPENSION LETTER WRITTEN |
| 2020-01-09 | LETTER OF SUSPENSION E-MAILED |
| 2020-01-09 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 2020-08-04 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| 2020-08-18 | SUSPENSION INQUIRY WRITTEN |
| 2020-08-18 | INQUIRY TO SUSPENSION E-MAILED |
| 2020-08-18 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| 2020-09-04 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| 2020-09-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-09-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-10-01 | SUSPENSION LETTER WRITTEN |
| 2020-10-01 | LETTER OF SUSPENSION E-MAILED |
| 2020-10-01 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 2021-02-11 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| 2021-02-17 | ASSIGNED TO LIE |
| 2021-02-18 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-02-18 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-03-01 | NON-FINAL ACTION WRITTEN |
| 2021-03-01 | NON-FINAL ACTION E-MAILED |
| 2021-03-01 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-09-01 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-09-01 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-09-01 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-10-01 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-10-01 | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST |
| 2021-10-01 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| 2021-10-12 | FINAL REFUSAL WRITTEN |
| 2021-10-12 | FINAL REFUSAL E-MAILED |
| 2021-10-12 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2021-10-13 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2021-10-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-10-13 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-10-16 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-10-25 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2021-11-09 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| 2021-11-29 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| 2021-12-02 | EXAMINERS AMENDMENT -WRITTEN |
| 2021-12-02 | EXAMINERS AMENDMENT E-MAILED |
| 2021-12-02 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2021-12-02 | EXAMINER'S AMENDMENT ENTERED |
| 2021-12-02 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-12-07 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2021-12-22 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2022-01-11 | PUBLISHED FOR OPPOSITION |
| 2022-01-11 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
